𝔖 Bobbio Scriptorium
✦   LIBER   ✦

System issues: Temporal and molecular characteristics of lacZ mutations in somatic tissues of transgenic mice

✍ Scribed by George R. Douglas; Jianli Jiao; John D. Gingerich; Lynda M. Soper; Jan A. Gossen


Publisher
John Wiley and Sons
Year
1996
Tongue
English
Weight
697 KB
Volume
28
Category
Article
ISSN
0893-6692

No coin nor oath required. For personal study only.

✦ Synopsis


In order to help establish criteria for optimizing p r o tocols for in vivo mutation studies, IacZ transgenic mice (MutaTM mouse) were treated with five consecutive daily doses of ethylnitrosourea (50 mg/kg), sampled at times up to 55 days after treatment, and mutant frequencies and DNA sequences determined for liver and bone marrow. In the bone marrow, the mutant frequency rose very rapidly in the first 5 days after treatment to 34 times the control frequency. Subsequently, there was a broad peak where the mutant frequency did not vary significantly, although it did appear to begin to decline after 45 days. In contrast, in the liver, the peak mutant frequency (1 1 times the control frequency) was not achieved until 35 days, after which there appeared to be a slow decline up to 55 days, which was not statistically significant. Once the maximum mutant frequency was reached, the mutation spec-tra in the two tissues were indistinguishable. In contrast to the G:C -+ A:T transitions in 5'-CpG sites characteristic of untreated mice, A:T -P T:A transversions and A:T -P G:C transitions were prominent in both liver and bone marrow of ENU-treated mice, suggesting the involvement of unrepaired 0'and 04-ethylthymine adducts. In addition, G:C -+ T:A transversions were induced in liver. This study demonstrates the possibility that although tissues may have different mutation fixation times, a single mutation fixation time equal to the longest time may be appropriate for in vivo mutation studies, provided that the mutation frequency does not decline appre ciably after the peak is reached. This study also illustrates the necessity of ensuring that mutation characteristics are determined after optimal fixation has occurred.


📜 SIMILAR VOLUMES


System issues: The genetic analysis of l
✍ Gregory R. Stuart; Nancy J. Gorelick; Julie L. Andrews; Johan G. de Boer; Barry 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 761 KB

However, the interpretation of data from transgenic animal assays is sometimes complicated by mutants that appear as sectored mutant lambda plaques. These mutants can form a significant fraction of the mutant plaques [Hayward et al. (1 995): Carcinogenesis 16:2429-24331. Thus, in order to accurately